|
Recent Developments |
|
27-DEC-10
Jupiter Bioscience announced that is negotiating a multi year supply contract worth Rs 750 million for peptide building blocks with large multinational big pharma companies based in Europe.
08-SEP-10
Macquarie Bank, on Wednesday sold shares in Jupiter Bioscience, engaged in the Macquarie Bank, on Wednesday sold shares in Jupiter Bioscience, engaged in the
Future Plans
The company aims to increase the R&D team to around 250 scien... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 31-Dec-2011(9) | 31-Mar-2011 (12) | 31-Mar-2010 (12) | | Net sales | 883.57 | 2532.55 | 1839.43 | | Other Income | 3.29 | 0.00 | 0.61 | | Total Income | 886.86 | 2532.55 | 1840.04 | | Cost of goods sold | 448.08 | 1433.29 | 883.67 | | OPBDIT | 438.78 | 1099.26 | 956.37 | | PAT | -106.04 | 334.15 | 308.24 | | Gross Block | - | - | - | | Equity capital | 624.34 | 624.34 | 161.34 | | EPS (Rs.) | - | 6.02 | 20.54 | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | 3.04 - 24.75 | 1.82 - 5.10 | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 49.5 | 43.4 | 52.0 | | Net margin (% of OI) | -12.0 | 13.2 | 16.8 |
|
|
Detailed Financials
|
|
|
|
|
